The legal landscape governing small and medium businesses witnessed a significant development following a landmark decision. The Supreme Court of India resolved complex jurisdictional and procedural ambiguities in Civil Appeals Nos. 1570 to 1578 of 2021 and Civil Appeals Nos. 1620 to 1622 of 2021. This ruling clarifies the intersection of the Micro, Small and Medium Enterprises Development Act of 2006 and the Arbitration and Conciliation Act of 1996. The Court passed the order addressing three primary legal issues that frequently arise in commercial disputes between buyers and registered suppliers.
Applicability of the Limitation Act
The first major question before the bench was whether the provisions of the Limitation Act of 1963 apply to statutory arbitration proceedings initiated under Section 18(3) of the MSMED Act. The Court affirmed that the Limitation Act strictly applies to these proceedings. Drawing upon Section 43 of the Arbitration and Conciliation Act, the judgment clarified that limitation rules govern arbitrations just as they govern ordinary court proceedings. Consequently, when a dispute moves from a failed conciliation to arbitration before a Facilitation Council, the statutory time limits for filing claims remain fully enforceable.
Maintainability of Counterclaims
A highly debated issue in this litigation was whether a buyer could file a counterclaim against a supplier during arbitration proceedings before the Micro and Small Enterprises Facilitation Council. Sellers argued that the MSMED Act is a beneficial legislation designed solely to protect their interests, implying that buyers should not be allowed to raise counterclaims in this specific forum.
The Court completely rejected this narrow interpretation. It highlighted that Section 18(3) of the MSMED Act incorporates the procedural framework of the Arbitration and Conciliation Act. Because Section 23 of the Arbitration Act explicitly permits respondents to submit counterclaims and setoffs, buyers possess the statutory right to defend themselves comprehensively. Furthermore, the Court noted that if counterclaims were barred, buyers could easily bypass the mandatory 75 percent pre-deposit requirement for challenging awards, which is a core protective feature of the MSMED Act. Prohibiting counterclaims would also force buyers to initiate parallel proceedings in civil courts, potentially leading to conflicting judicial findings.
The Timing of MSME Registration
The third pivotal ruling addressed the exact timing required for a supplier to obtain its MSME registration. The Court had to determine if an entity could claim the protective benefits of the MSMED Act if it registered after the contract was signed and the goods were fully supplied.
Taking a firm stance, the Court stated that to seek these statutory benefits, a seller must possess a valid registration under the MSMED Act on the exact date of entering into the contract. A supplier cannot assume the legal status of a classified enterprise retrospectively by filing a memorandum after the transaction is complete. Registration applies prospectively to future supply contracts and services. Since the appellants in the connected appeals did not have their registration during the relevant transaction period, they were not entitled to invoke the special statutory arbitration mechanism.
Conclusion
After conducting a harmonious construction of the competing statutes, the Court found that the MSMED Act prevails as a special legislation while still accommodating the procedural safeguards of general arbitration laws. The Court passed the order dismissing the civil appeals, thereby upholding the maintainability of counterclaims by buyers and strictly enforcing the prospective nature of MSME registrations.
Read the Judgment here.